Author Correction: Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells

Rong Huang^#¹, Yingbin Wang^#², Haitao Teng², Mengjun Xu², Kexin He², Yingzhuo Shen², Guo Guo^{2

3}, Xinyu Feng², Tianhan Li⁴, Binhui Zhou⁵, Marc Bajenoff³, Toby Lawrence^{3

6}, Yinming Liang^{7

8}, Liaoxun Lu⁹, Lichen Zhang^{10

11}

Affiliations

¹ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. huangrong@gris.org.cn.
² Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China.
³ Centre d'immunologie de Marseille-Luminy, Aix-Marseille University, CNRS, INSERM, Marseille, France.
⁴ School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
⁵ Institute of Psychiatry and Neuroscience, Xinxiang Medical University, Xinxiang, China.
⁶ Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King's College London, London, UK.
⁷ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. yinming.liang@foxmail.com.
⁸ Center of Disease Model and Immunology, Hunan Academy of Chinese Medicine, Changsha, China. yinming.liang@foxmail.com.
⁹ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. luliaoxun@gris.org.cn.
¹⁰ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. zhanglichen@gris.org.cn.
¹¹ Center of Disease Model and Immunology, Hunan Academy of Chinese Medicine, Changsha, China. zhanglichen@gris.org.cn.

^# Contributed equally.

Published Erratum

Rong Huang et al. BMC Biol. 2025.

. 2025 Jun 15;23(1):165.

doi: 10.1186/s12915-025-02285-w.

¹ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. huangrong@gris.org.cn.
² Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China.
³ Centre d'immunologie de Marseille-Luminy, Aix-Marseille University, CNRS, INSERM, Marseille, France.
⁴ School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
⁵ Institute of Psychiatry and Neuroscience, Xinxiang Medical University, Xinxiang, China.
⁶ Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King's College London, London, UK.
⁷ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. yinming.liang@foxmail.com.
⁸ Center of Disease Model and Immunology, Hunan Academy of Chinese Medicine, Changsha, China. yinming.liang@foxmail.com.
⁹ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. luliaoxun@gris.org.cn.
¹⁰ Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China. zhanglichen@gris.org.cn.
¹¹ Center of Disease Model and Immunology, Hunan Academy of Chinese Medicine, Changsha, China. zhanglichen@gris.org.cn.

^# Contributed equally.

No abstract available

Erratum for

Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells.
Huang R, Wang Y, Teng H, Xu M, He K, Shen Y, Guo G, Feng X, Li T, Zhou B, Bajenoff M, Lawrence T, Liang Y, Lu L, Zhang L. Huang R, et al. BMC Biol. 2025 May 15;23(1):135. doi: 10.1186/s12915-025-02237-4. BMC Biol. 2025. PMID: 40375241 Free PMC article.

1. Huang R, et al. Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells. BMC Biol. 2025;23:135. 10.1186/s12915-025-02237-4. - DOI - PMC - PubMed